[Skip to Content]
[Skip to Content Landing]
August 1985

Selection of Patients for Intensive Insulin Therapy

Author Affiliations

Department of Medicine and Physiology Endocrine Research Unit Mayo Clinic Rochester, MN 55905

Arch Intern Med. 1985;145(8):1383-1384. doi:10.1001/archinte.1985.00360080053004

During the last ten years, there has been a substantial accumulation of evidence indicating that poor metabolic control plays an important role in the development of the so-called long-term complications of diabetes (retinopathy, neuropathy, nephropathy, and premature atherosclerosis).1 On the basis of this evidence, the American Diabetes Association has recently recommended that "it is logical and prudent to reduce blood glucose levels to normal if such attempts are not grossly disturbing to the lifestyle of the patient."2 Self-monitoring of blood glucose levels,3 mimicking of normal insulin secretory patterns by preprandial administration of insulin—so-called intensive insulin therapy,4 and use of glycosylated hemoglobin determination for objective evaluation of long-term control5 have made achievement of near normoglycemia a practical goal for most patients taking insulin.

In intensive insulin programs, meal-related and overnight insulin requirements are usually met either by use of pumps (continuous subcutaneous insulin infusion) or by

First Page Preview View Large
First page PDF preview
First page PDF preview